122 related articles for article (PubMed ID: 38678852)
21. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy.
Eraslan C; Acarer A; Guneyli S; Akyuz E; Aydin E; Colakoglu Z; Kitis O; Calli MC
Neurol Res; 2019 Feb; 41(2):110-117. PubMed ID: 30373485
[TBL] [Abstract][Full Text] [Related]
22. MRI measurements of brainstem structures in patients with vascular parkinsonism, progressive supranuclear palsy, and Parkinson's disease.
Kim BC; Choi SM; Choi KH; Nam TS; Kim JT; Lee SH; Park MS; Yoon W
Neurol Sci; 2017 Apr; 38(4):627-633. PubMed ID: 28078564
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
Jabbari E; Holland N; Chelban V; Jones PS; Lamb R; Rawlinson C; Guo T; Costantini AA; Tan MMX; Heslegrave AJ; Roncaroli F; Klein JC; Ansorge O; Allinson KSJ; Jaunmuktane Z; Holton JL; Revesz T; Warner TT; Lees AJ; Zetterberg H; Russell LL; Bocchetta M; Rohrer JD; Williams NM; Grosset DG; Burn DJ; Pavese N; Gerhard A; Kobylecki C; Leigh PN; Church A; Hu MTM; Woodside J; Houlden H; Rowe JB; Morris HR
JAMA Neurol; 2020 Mar; 77(3):377-387. PubMed ID: 31860007
[TBL] [Abstract][Full Text] [Related]
24. Track density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonism.
Nigro S; Barbagallo G; Bianco MG; Morelli M; Arabia G; Quattrone A; Gasparini S; Cascini GL; Quattrone A
Parkinsonism Relat Disord; 2019 Dec; 69():23-29. PubMed ID: 31665684
[TBL] [Abstract][Full Text] [Related]
25. Radiomics on routine T1-weighted MRI can delineate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy.
Tupe-Waghmare P; Rajan A; Prasad S; Saini J; Pal PK; Ingalhalikar M
Eur Radiol; 2021 Nov; 31(11):8218-8227. PubMed ID: 33945022
[TBL] [Abstract][Full Text] [Related]
26. Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
Hansson O; Janelidze S; Hall S; Magdalinou N; Lees AJ; Andreasson U; Norgren N; Linder J; Forsgren L; Constantinescu R; Zetterberg H; Blennow K;
Neurology; 2017 Mar; 88(10):930-937. PubMed ID: 28179466
[TBL] [Abstract][Full Text] [Related]
27. Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy.
Nigro S; Arabia G; Antonini A; Weis L; Marcante A; Tessitore A; Cirillo M; Tedeschi G; Zanigni S; Calandra-Buonaura G; Tonon C; Pezzoli G; Cilia R; Zappia M; Nicoletti A; Cicero CE; Tinazzi M; Tocco P; Cardobi N; Quattrone A
Eur Radiol; 2017 Jun; 27(6):2665-2675. PubMed ID: 27761709
[TBL] [Abstract][Full Text] [Related]
28. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
[TBL] [Abstract][Full Text] [Related]
29. MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP.
Mangesius S; Hussl A; Krismer F; Mahlknecht P; Reiter E; Tagwercher S; Djamshidian A; Schocke M; Esterhammer R; Wenning G; Müller C; Scherfler C; Gizewski ER; Poewe W; Seppi K
Parkinsonism Relat Disord; 2018 Jan; 46():47-55. PubMed ID: 29126761
[TBL] [Abstract][Full Text] [Related]
30. Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson's disease on MRI.
Müller SJ; Khadhraoui E; Hansen N; Jamous A; Langer P; Wiltfang J; Riedel CH; Bouter C; van Riesen C; Maass F; Bartl M; Lange C; Ernst M
BMC Neurol; 2023 Mar; 23(1):114. PubMed ID: 36944914
[TBL] [Abstract][Full Text] [Related]
31. Automated brainstem volumetry can aid in the diagnostics of parkinsonian disorders.
Sjöström H; Granberg T; Hashim F; Westman E; Svenningsson P
Parkinsonism Relat Disord; 2020 Oct; 79():18-25. PubMed ID: 32858488
[TBL] [Abstract][Full Text] [Related]
32. PTPRC Expression in Blood is Downregulated in Parkinson's and Progressive Supranuclear Palsy Disorders.
Bottero V; Santiago JA; Potashkin JA
J Parkinsons Dis; 2018; 8(4):529-537. PubMed ID: 30248063
[TBL] [Abstract][Full Text] [Related]
33. Serum neurofilament light chain in progressive supranuclear palsy.
Donker Kaat L; Meeter LH; Chiu WZ; Melhem S; Boon AJW; Blennow K; Zetterberg H; van Swieten JC
Parkinsonism Relat Disord; 2018 Nov; 56():98-101. PubMed ID: 29937097
[TBL] [Abstract][Full Text] [Related]
34. Video-oculographic biomarkers for evaluating vertical ocular dysfunction in progressive supranuclear palsy.
Quattrone A; Crasà M; Morelli M; Vescio B; Augimeri A; Gramigna V; Quattrone A
Parkinsonism Relat Disord; 2022 Jun; 99():84-90. PubMed ID: 35642995
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients.
Sankhla CS; Patil KB; Sawant N; Gupta S
Neurol India; 2016; 64(2):239-45. PubMed ID: 26954800
[TBL] [Abstract][Full Text] [Related]
36. Utility of Multi-Modal MRI for Differentiating of Parkinson's Disease and Progressive Supranuclear Palsy Using Machine Learning.
Talai AS; Sedlacik J; Boelmans K; Forkert ND
Front Neurol; 2021; 12():648548. PubMed ID: 33935946
[No Abstract] [Full Text] [Related]
37. Swallow tail sign on susceptibility map-weighted imaging (SMWI) for disease diagnosing and severity evaluating in parkinsonism.
Liu X; Wang N; Chen C; Wu PY; Piao S; Geng D; Li Y
Acta Radiol; 2021 Feb; 62(2):234-242. PubMed ID: 32380911
[TBL] [Abstract][Full Text] [Related]
38. Neuropsychological assessment could distinguish among different clinical phenotypes of progressive supranuclear palsy: A Machine Learning approach.
Vaccaro MG; Sarica A; Quattrone A; Chiriaco C; Salsone M; Morelli M; Quattrone A
J Neuropsychol; 2021 Sep; 15(3):301-318. PubMed ID: 33231380
[TBL] [Abstract][Full Text] [Related]
39. Automated Categorization of Parkinsonian Syndromes Using Magnetic Resonance Imaging in a Clinical Setting.
Chougar L; Faouzi J; Pyatigorskaya N; Yahia-Cherif L; Gaurav R; Biondetti E; Villotte M; Valabrègue R; Corvol JC; Brice A; Mariani LL; Cormier F; Vidailhet M; Dupont G; Piot I; Grabli D; Payan C; Colliot O; Degos B; Lehéricy S
Mov Disord; 2021 Feb; 36(2):460-470. PubMed ID: 33137232
[TBL] [Abstract][Full Text] [Related]
40. Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders.
Zhang P; Chen J; Cai T; He C; Li Y; Li X; Chen Z; Wang L; Zhang Y
Front Aging Neurosci; 2022; 14():909552. PubMed ID: 35992605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
